Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines

Cervical cancer has a poor prognosis and is the fourth most common cancer among women. Dihydromyricetin (DHM), a flavonoid compound, exhibits several pharmacological activities, including anticancer effects; however, the effects of DHM on cervical cancer have received insufficient research attention...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsin, Min-Chieh, Hsiao, Yi-Hsuan, Chen, Pei-Ni, Lin, Chiao-Wen, Wang, Po-Hui, Yang, Shun-Fa, Lee, Chung-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735508/
https://www.ncbi.nlm.nih.gov/pubmed/36499426
http://dx.doi.org/10.3390/ijms232315106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735508/
https://www.ncbi.nlm.nih.gov/pubmed/36499426
http://dx.doi.org/10.3390/ijms232315106

Ejemplares similares